Giranda; Vincent L.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Giranda; Vincent L..The latest application filed is for "combination therapy with parp inhibitors".
Company Profile
0.21.46
- Giranda; Vincent L. - Gurnee IL
Patent Activity
| Patent | Date |
|---|---|
| Combination Therapy With Parp Inhibitors App 20160324829 - Donawho; Cherrie K. ; et al. | 2016-11-10 |
| Inhibitors of poly(ADP-ribose)polymerase Grant 9,283,222 - Gandhi , et al. March 15, 2 | 2016-03-15 |
| Combination Therapy With Parp Inhibitors App 20150005355 - Donawho; Cherrie K. ; et al. | 2015-01-01 |
| Combination Therapy With Parp Inhibitors App 20150005354 - Giranda; Vincent L. ; et al. | 2015-01-01 |
| 1h-benzimidazole-4-carboxamides Substituted With Phenyl At The 2-position Are Potent Parp Inhibitors App 20140296235 - Penning; Thomas D. ; et al. | 2014-10-02 |
| Pyrazoloquinolones Are Potent Parp Inhibitors App 20140213610 - Penning; Thomas D. ; et al. | 2014-07-31 |
| Inhibitors Of Poly(adp-ribose)polymerase App 20140212509 - Gandhi; Virajkumar B. ; et al. | 2014-07-31 |
| 1H-benzimidazole-4-carboxamides substituted with phenyl at the 2-position are potent PARP inhibitors Grant 8,697,736 - Penning , et al. April 15, 2 | 2014-04-15 |
| Parp Inhibitors For The Treatment Of Cipn App 20140093585 - Giranda; Vincent L. ; et al. | 2014-04-03 |
| Veliparib In Combination With Whole Brain Radiation Therapy For The Treatment Of Brain Metastases App 20130310625 - Giranda; Vincent L. | 2013-11-21 |
| Pyrazoloquinolones are potent PARP inhibitors Grant 8,546,368 - Penning , et al. October 1, 2 | 2013-10-01 |
| Combination Therapy With Parp Inhibitors App 20130225647 - Donawho; Cherrie K. ; et al. | 2013-08-29 |
| Inhibitors of poly(ADP-ribose)polymerase Grant 8,466,150 - Gandhi , et al. June 18, 2 | 2013-06-18 |
| Combination Therapy With Parp Inhibitors App 20120264795 - Donawho; Cherrie K. ; et al. | 2012-10-18 |
| Combination Therapy With Parp Inhibitors App 20120190720 - Giranda; Vincent L. ; et al. | 2012-07-26 |
| 2-substituted-1H-benzimidazole-4-carboxamides are PARP inhibitors Grant 8,217,070 - Zhu , et al. July 10, 2 | 2012-07-10 |
| Potent PARP inhibitors Grant 8,183,250 - Penning , et al. May 22, 2 | 2012-05-22 |
| Substituted thieno[3,2-d]pyrimidine PIM kinase inhibitors as cancer chemotherapeutics Grant 8,148,384 - Penning , et al. April 3, 2 | 2012-04-03 |
| Combination Therapy With Parp Inhibitors App 20120045524 - Wernet; Wolfgang ; et al. | 2012-02-23 |
| Benzimidazole Poly(adp Ribose)polymerase Inhibitors App 20120046303 - Gandhi; Virajkumar B. ; et al. | 2012-02-23 |
| Benzimidazole poly(ADP ribose)polymerase inhibitors Grant 8,067,613 - Gandhi , et al. November 29, 2 | 2011-11-29 |
| Substituted 1H-benzimidazole-4-carboxamides are potent PARP inhibitors Grant 7,999,117 - Giranda , et al. August 16, 2 | 2011-08-16 |
| Combination Therapy With Parp Inhibitors App 20110151023 - Wernet; Wolfgang ; et al. | 2011-06-23 |
| Combination Therapy With Parp Inhibitors App 20110152336 - Wernet; Wolfgang ; et al. | 2011-06-23 |
| Cyclobut-3-ene-1,2,-dione inhibitors of polo-like kinases Grant 7,956,185 - Diebold , et al. June 7, 2 | 2011-06-07 |
| 2-substituted-1h-benzimidazole-4-carboxamides Are Parp Inhibitors App 20100234425 - Zhu; Gui-Dong ; et al. | 2010-09-16 |
| Pyrroloquinoxalinone inhibitors of poly(ADP-ribose)polymerase Grant 7,790,721 - Giranda , et al. September 7, 2 | 2010-09-07 |
| 2-substituted-1 h-benzimidazile-4-carboxamides are PARP inhibitors Grant 7,728,026 - Zhu , et al. June 1, 2 | 2010-06-01 |
| Potent Parp Inhibitors App 20090298858 - Penning; Thomas D. ; et al. | 2009-12-03 |
| Substituted 1H-benzimidazole-4-carboxamides are potent PARP inhibitors Grant 7,595,406 - Penning , et al. September 29, 2 | 2009-09-29 |
| Substituted 1h-benzimidazole-4-carboxamides Are Potent Parp Inhibitors App 20090186877 - Giranda; Vincent L. ; et al. | 2009-07-23 |
| 1H-benzimidazole-4-carboxamides substituted with a quaternary carbon at the 2-position are potent PARP inhibitors Grant 7,550,603 - Zhu , et al. June 23, 2 | 2009-06-23 |
| Combination Therapy With Parp Inhibitors App 20090029966 - Donawho; Cherrie K. ; et al. | 2009-01-29 |
| Benzimidazole Poly(adp Ribose)polymerase Inhibitors App 20090030016 - Gandhi; Virajkumar B. ; et al. | 2009-01-29 |
| Substituted 1H-benzimidazole-4-carboxamides are potent PARP inhibitors Grant 7,462,724 - Penning , et al. December 9, 2 | 2008-12-09 |
| Combination Therapy With Parp Inhibitors App 20080293795 - Donawho; Cherrie K. ; et al. | 2008-11-27 |
| Combination Therapy With Parp Inhibitors App 20080280867 - Giranda; Vincent L. ; et al. | 2008-11-13 |
| Inhibitors Of Poly(adp-ribose)polymerase App 20080269234 - Gandhi; Virajkumar B. ; et al. | 2008-10-30 |
| Inhibitors Of Poly(adp-ribose)polymerase App 20080161280 - Gandhi; Virajkumar B. ; et al. | 2008-07-03 |
| Pim Kinase Inhibitors As Cancer Chemotherapeutics App 20080161559 - Penning; Thomas D. ; et al. | 2008-07-03 |
| Pim Kinase Inhibitors As Cancer Chemotherapeutics App 20080161578 - Penning; Thomas D. ; et al. | 2008-07-03 |
| Inhibitors Of Poly(adp-ribose)polymerase App 20080161292 - Giranda; Vincent L. ; et al. | 2008-07-03 |
| Combination Therapy With Parp Inhibitors App 20080146638 - Giranda; Vincent L. ; et al. | 2008-06-19 |
| Inhibitors Of Polo-like Kinases App 20080015192 - Diebold; Robert B. ; et al. | 2008-01-17 |
| Potent PARP Inhibitors App 20080015182 - Penning; Thomas D. ; et al. | 2008-01-17 |
| Substituted 1h-benzimidazole-4-carboxamides Are Potent Parp Inhibitors App 20070270476 - Penning; Thomas D. ; et al. | 2007-11-22 |
| Combination Therapy with Parp Inhibitors App 20070265324 - Wernet; Wolfgang ; et al. | 2007-11-15 |
| Substituted 1h-benzimidazole-4-carboxamides Are Potent Parp Inhibitors App 20070259937 - Giranda; Vincent L. ; et al. | 2007-11-08 |
| Pyrazoloquinolones Are Potent Parp Inhibitors App 20070249597 - PENNING; THOMAS D. ; et al. | 2007-10-25 |
| 1h-benzimidazole-4-carboxamides Substituted With Phenyl At The 2-position Are Potent Parp Inhibitors App 20070179136 - Penning; Thomas D. ; et al. | 2007-08-02 |
| Substituted 1h-benzimidazole-4-carboxamides Are Potent Parp Inhibitors App 20070112047 - Penning; Thomas D. ; et al. | 2007-05-17 |
| 1H-benzimidazole-4-carboxamides substituted with a quaternary carbon at the 2-position are potent PARP inhibitors App 20060229289 - Zhu; Gui-Dong ; et al. | 2006-10-12 |
| 2-Substituted-1 H-benzimidazile-4-carboxamides are PARP inhibitors App 20060229351 - Zhu; Gui-Dong ; et al. | 2006-10-12 |
| Inhibitors of neuraminidases Grant 6,831,096 - Maring , et al. December 14, 2 | 2004-12-14 |
| Kinase inhibitors Grant 6,831,175 - Li , et al. December 14, 2 | 2004-12-14 |
| Inhibitors of neuraminidases App 20040097471 - Maring, Clarence J. ; et al. | 2004-05-20 |
| Peptide inhibitors of Akt and uses thereof App 20040038883 - Luo, Yan ; et al. | 2004-02-26 |
| Kinase inhibitors App 20030199511 - Li, Qun ; et al. | 2003-10-23 |
| Kinase inhibitors App 20030187026 - Li, Qun ; et al. | 2003-10-02 |
| Peptide inhibitors of Akt and uses thereof App 20030181366 - Luo, Yan ; et al. | 2003-09-25 |
| DNA encoding human Cid1 App 20020187522 - Luo, Yan ; et al. | 2002-12-12 |
| Inhibitors of neuraminidases Grant 6,455,571 - Maring , et al. September 24, 2 | 2002-09-24 |
| DNA encoding human Cid2 App 20020127556 - Luo, Yan ; et al. | 2002-09-12 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 